NCT03303183 is a NA clinical trial of Standard Impression technique in Ear Anatomy, sponsored by Sonova AG.

Who is sponsoring NCT03303183?

NCT03303183 is sponsored by Sonova AG.

What drugs are being tested in NCT03303183?

Interventions in NCT03303183: Standard Impression technique, Direct Ear Scanner.

What condition does NCT03303183 study?

NCT03303183 studies Ear Anatomy.

Is NCT03303183 still recruiting?

NCT03303183 is currently completed. Last updated 26 November 2019.

Last reviewed 2019-11-26 · How we verify

NCT03303183

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Benchmark Ear Impression Techniques

Completed NA Last updated 26 November 2019

What this trial tests

NA trial testing Standard Impression technique in Ear Anatomy in 25 participants. Completed in 15 December 2018.

Timeline

23 October 2017

Primary endpoint
15 December 2018

15 December 2018

Quick facts

Lead sponsor	Sonova AG
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	single
Primary purpose	basic science
Enrollment	25
Start date	23 October 2017
Primary completion	15 December 2018
Estimated completion	15 December 2018
Sites	1 location across Switzerland

Drugs / interventions tested

Standard Impression technique
Direct Ear Scanner

Conditions studied

Ear Anatomy — all drugs for Ear Anatomy →

Sponsor

Sonova AG — full company profile →

Who can join

18 and older, any sex, with Ear Anatomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the scan quality of the direct ear scanner concerning consistency, accuracy and reliability and to compare the data to common silicone ear impressions by benchmarking the outcome of each impression technique on custom product dummies on participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sonova AG trials

Trials by the same sponsor.

NCT07526428 — Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment · NA · enrolling by invitation
NCT07501312 — Remote Microphone Performance Comparison in Adults With Hearing Loss · NA · enrolling by invitation
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
NCT06957730 — A Comparison of Hearing Aid Noise Programs on Speech Intelligibility · NA · completed
NCT06746038 — Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03303183 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sonova AG
Last refreshed: 26 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03303183.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing